[1]
V. Ranpura, S. Hapani, J. Chuang, and S. Wu, “Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials”, AO, vol. 49, no. 3, pp. 287–297, Jan. 2010.